Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4HIX

Crystal structure of a humanised 3D6 Fab bound to amyloid beta peptide

Summary for 4HIX
Entry DOI10.2210/pdb4hix/pdb
Related2IPU 3BAE
DescriptorHumanized 3D6 Fab heavy chain, Humanized 3D6 Fab light chain, Beta-amyloid protein 40, ... (4 entities in total)
Functional Keywordsimmunoglobulin, immunotherapy candidate, amyloid beta peptide, protein fibril-immune system complex, protein fibril/immune system
Biological sourcehomo Sapiens, Mus musculus (human, mouse)
More
Cellular locationMembrane; Single-pass type I membrane protein: P05067
Total number of polymer chains3
Total formula weight51694.54
Authors
Miles, L.A.,Crespi, G.A.N.,Parker, M.W. (deposition date: 2012-10-12, release date: 2013-03-13, Last modification date: 2024-11-20)
Primary citationMiles, L.A.,Crespi, G.A.,Doughty, L.,Parker, M.W.
Bapineuzumab captures the N-terminus of the Alzheimer's disease amyloid-beta peptide in a helical conformation.
Sci Rep, 3:1302-1302, 2013
Cited by
PubMed Abstract: Bapineuzumab is a humanized antibody developed by Pfizer and Johnson & Johnson targeting the amyloid (Aβ) plaques that underlie Alzheimer's disease neuropathology. Here we report the crystal structure of a Fab-Aβ peptide complex that reveals Bapineuzumab surprisingly captures Aβ in a monomeric helical conformation at the N-terminus. Microscale thermophoresis suggests that the Fab binds soluble Aβ(1-40) with a K(D) of 89 (±9) nM. The structure explains the antibody's exquisite selectivity for particular Aβ species and why it cannot recognize N-terminally modified or truncated Aβ peptides.
PubMed: 23416764
DOI: 10.1038/srep01302
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.204 Å)
Structure validation

237423

PDB entries from 2025-06-11

PDB statisticsPDBj update infoContact PDBjnumon